Shared and distinct aspects of the sepsis transcriptomic response to fecal peritonitis and pneumonia

American Journal of Respiratory and Critical Care Medicine

Volumn 196, Issue 3, 2017, Pages 328-339

  Burnham, Katie L ^a   Davenport, Emma E ^a   Radhakrishnan, Jayachandran ^a   Humburg, Peter ^a   Gordon, Anthony C ^b   Hutton, Paula ^c   Svoren Jabalera, Eduardo ^d   Garrard, Christopher ^c   Hill, Adrian V S ^a   Hinds, Charles J ^d   Knight, Julian C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Gene expression; Immune; Patient stratification; Septic

Indexed keywords

INITIATION FACTOR 2; INTERFERON; INTERLEUKIN 3; TRANSCRIPTOME;

ADULT; AGED; ANTIGEN PRESENTATION; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENETIC VARIATION; HUMAN; IMMUNE RESPONSE; INTENSIVE CARE UNIT; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATURAL KILLER CELL; PERITONITIS; PERSONALIZED MEDICINE; PHAGOSOME; PRIORITY JOURNAL; PROGNOSIS; SEPSIS; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS; BLOOD; COMMUNITY ACQUIRED INFECTION; FECES; GENETICS; MIDDLE AGED; PNEUMONIA; PROCEDURES; PROSPECTIVE STUDY;

AGED; COMMUNITY-ACQUIRED INFECTIONS; FECES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; PERITONITIS; PNEUMONIA; PROSPECTIVE STUDIES; SEPSIS; TRANSCRIPTOME;

EID: 85026823884     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201608-1685OC     Document Type: Article

References (46)

1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016;315:801-810.
2. Marshall JC. Why have clinical trials in sepsis failed?. Trends Mol Med 2014;20:195-203.
3. Cohen J, Vincent JL, Adhikari NK, Machado FR, Angus DC, Calandra T, Jaton K, Giulieri S, Delaloye J, Opal S, et al. Sepsis: A roadmap for future research. Lancet Infect Dis 2015;15:581-614.
4. Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: From cellular dysfunctions to immunotherapy. Nat Rev Immunol 2013;13:862-874.
5. Davenport EE, Burnham KL, Radhakrishnan J, Humburg P, Hutton P, Mills TC, Rautanen A, Gordon AC, Garrard C, Hill AVS, et al. Genomic landscape of the individual host response and outcomes in sepsis: A prospective cohort study. Lancet Respir Med 2016;4:259-271.
6. Ramilo O, Allman W, Chung W, Mejias A, Ardura M, Glaser C, Wittkowski KM, Piqueras B, Banchereau J, Palucka AK, et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 2007;109:2066-2077.
7. Yu SL, Chen HW, Yang PC, Peck K, Tsai MH, Chen JJ, Lin FY. Differential gene expression in gram-negative and gram-positive sepsis. Am J Respir Crit Care Med 2004;169:1135-1143.
8. Feezor RJ, Oberholzer C, Baker HV, Novick D, Rubinstein M, Moldawer LL, Pribble J, Souza S, Dinarello CA, Ertel W, et al. Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria. Infect Immun 2003;71: 5803-5813.
9. Tang BM, McLean AS, Dawes IW, Huang SJ, Cowley MJ, Lin RC. Geneexpression profiling of gram-positive and gram-negative sepsis in critically ill patients. Crit Care Med 2008;36:1125-1128.
10. Maslove DM, Wong HR. Gene expression profiling in sepsis: Timing, tissue, and translational considerations. Trends Mol Med 2014;20: 204-213.
11. Scicluna BP, Klein Klouwenberg PM, van Vught LA, Wiewel MA, Ong DS, Zwinderman AH, Franitza M, Toliat MR, Nürnberg P, Hoogendijk AJ, et al. A molecular biomarker to diagnose community-acquired pneumonia on intensive care unit admission. Am J Respir Crit Care Med 2015;192:826-835.
12. Sweeney TE, Shidham A, Wong HR, Khatri P. A comprehensive timecourse-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set. Sci Transl Med 2015;7:287ra71.
13. Sweeney TE, Wong HR, Khatri P. Robust classification of bacterial and viral infections via integrated host gene expression diagnostics. Sci Transl Med 2016;8:346ra91.
14. Krepel CJ, Gohr CM, Edmiston CE, Condon RE. Surgical sepsis: Constancy of antibiotic susceptibility of causative organisms. Surgery 1995;117:505-509.
15. Marik PE; Norasept II Study Investigators. The clinical features of severe community-acquired pneumonia presenting as septic shock. J Crit Care 2000;15:85-90.
16. Weiss T, Shalit I, Blau H, Werber S, Halperin D, Levitov A, Fabian I. Antiinflammatory effects of moxifloxacin on activated human monocytic cells: Inhibition of NF-kB and mitogen-activated protein kinase activation and of synthesis of proinflammatory cytokines. Antimicrob Agents Chemother 2004;48:1974-1982.
17. Kovaleva A, Remmelts HH, Rijkers GT, Hoepelman AI, Biesma DH, Oosterheert JJ. Immunomodulatory effects of macrolides during community-acquired pneumonia: A literature review. J Antimicrob Chemother 2012;67:530-540.
18. Tridente A, Clarke GM, Walden A, McKechnie S, Hutton P, Mills GH, Gordon AC, Holloway PA, Chiche JD, Bion J, et al.; GenOSept Investigators. Patients with faecal peritonitis admitted to European intensive care units: An epidemiological survey of the GenOSept cohort. Intensive Care Med 2014;40:202-210.
19. Burnham K, Davenport E, Radhakrishnan J, Svoren-Jabalera E, Humburg P, Hutton P, Gordon A, Hill A, Hinds C, Knight J. Shared and specific features of the individual transcriptomic response in sepsis due to faecal peritonitis. Poster presented at the American Society of Human Genetics 2016 annual meeting. October 18-22, 2016, Vancouver, BC, Canada. Poster 3316W.
20. Burnham KL, Davenport EE, Radhakrishnan J, Humburg P, Hutton P, Garrard C, Hinds CJ, Knight JC. Heterogeneity in the individual transcriptomic response to severe sepsis. Presented at the 13th International Congress of Human Genetics. April 3-7, 2016, Kyoto, Japan.
21. Angus DC, Marrie TJ, Obrosky DS, Clermont G, Dremsizov TT, Coley C, Fine MJ, Singer DE, Kapoor WN. Severe community-acquired pneumonia: Use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria. Am J Respir Crit Care Med 2002;166:717-723.
22. Walden AP, Clarke GM, McKechnie S, Hutton P, Gordon AC, Rello J, Chiche JD, Stueber F, Garrard CS, Hinds CJ; ESICM/ECCRN GenOSept Investigators. Patients with community acquired pneumonia admitted to European intensive care units: An epidemiological survey of the GenOSept cohort. Crit Care 2014;18:R58.
23. Huber W, von Heydebreck A, Sültmann H, Poustka A, Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 2002;18 (Suppl 1):S96-S104.
24. Wong HR, Cvijanovich N, Lin R, Allen GL, Thomas NJ, Willson DF, Freishtat RJ, Anas N, Meyer K, Checchia PA, et al. Identification of pediatric septic shock subclasses based on genome-wide expression profiling. BMC Med 2009;7:34.
25. Shrestha N, Bahnan W, Wiley DJ, Barber G, Fields KA, Schesser K. Eukaryotic initiation factor 2 (eIF2) signaling regulates proinflammatory cytokine expression and bacterial invasion. J Biol Chem 2012;287:28738-28744.
26. Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, Hayden DL, Hennessy L, Moore EE, Minei JP, et al.; Inflammation and Host Response to Injury Large-Scale Collaborative Research Program. A genomic storm in critically injured humans. J Exp Med 2011;208:2581-2590.
27. Ioannidis I, McNally B, Willette M, Peeples ME, Chaussabel D, Durbin JE, Ramilo O, Mejias A, Flaño E. Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection. J Virol 2012;86:5422-5436.
28. Zhou Z, Xue Q, Wan Y, Yang Y, Wang J, Hung T. Lysosome-associated membrane glycoprotein 3 is involved in influenza A virus replication in human lung epithelial (A549) cells. Virol J 2011;8:384.
29. Cazalis MA, Lepape A, Venet F, Frager F, Mougin B, Vallin H, Paye M, Pachot A, Monneret G. Early and dynamic changes in gene expression in septic shock patients: A genome-wide approach. Intensive Care Med Exp 2014;2:20.
30. Tai YC, Speed TP. On gene ranking using replicated microarray time course data. Biometrics 2009;65:40-51.
31. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman SD II, Kreisel D, Krupnick AS, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 2011;306:2594-2605.
32. Pena OM, Hancock DG, Lyle NH, Linder A, Russell JA, Xia J, Fjell CD, Boyd JH, Hancock RE. An endotoxin tolerance signature predicts sepsis and organ dysfunction at initial clinical presentation. EBioMedicine 2014;1:64-71.
33. Jenner RG, Young RA. Insights into host responses against pathogens from transcriptional profiling. Nat Rev Microbiol 2005;3:281-294.
34. Mira JC, Szpila BE, Nacionales DC, Lopez MC, Gentile LF, Mathias BJ, Vanzant EL, Ungaro R, Holden D, Rosenthal MD, et al. Patterns of gene expression among murine models of hemorrhagic shock/trauma and sepsis. Physiol Genomics 2016;48:135-144.
35. Talwar S, Munson PJ, Barb J, Fiuza C, Cintron AP, Logun C, Tropea M, Khan S, Reda D, Shelhamer JH, et al. Gene expression profiles of peripheral blood leukocytes after endotoxin challenge in humans. Physiol Genomics 2006;25:203-215.
36. Phua J, Ngerng W, See K, Tay C, Kiong T, Lim H, Chew M, Yip H, Tan A, Khalizah H, et al. Characteristics and outcomes of culturenegative versus culture-positive severe sepsis. Crit Care 2013;17: R202.
37. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, et al.; EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302:2323-2329.
38. Macosko EZ, Basu A, Satija R, Nemesh J, Shekhar K, Goldman M, Tirosh I, Bialas AR, Kamitaki N, Martersteck EM, et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell 2015;161:1202-1214.
39. Aneja R, Carcillo J. Differences between adult and pediatric septic shock. Minerva Anestesiol 2011;77:986-992.
40. Wheeler DS, Wong HR, Zingarelli B. Pediatric sepsis: Part I. "Children are not small adults!" Open Inflamm J 2011;4:4-15.
41. Wong HR, Cvijanovich NZ, Anas N, Allen GL, Thomas NJ, Bigham MT, Weiss SL, Fitzgerald J, Checchia PA, Meyer K, et al. Developing a clinically feasible personalized medicine approach to pediatric septic shock. Am J Respir Crit Care Med 2015;191:309-315.
42. del Fresno C, García-Rio F, Gómez-Piña V, Soares-Schanoski A, Fernández-Ruíz I, Jurado T, Kajiji T, Shu C, Marín E, Gutierrez del Arroyo A, et al. Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: Demonstration in isolated monocytes from cystic fibrosis patients. J Immunol 2009;182:6494-6507.
43. Pena OM, Pistolic J, Raj D, Fjell CD, Hancock RE. Endotoxin tolerance represents a distinctive state of alternative polarization (M2) in human mononuclear cells. J Immunol 2011;186:7243-7254.
44. Conner SD, Schmid SL. Identification of an adaptor-associated kinase, AAK1, as a regulator of clathrin-mediated endocytosis. J Cell Biol 2002;156:921-929.
45. Veiga E, Guttman JA, Bonazzi M, Boucrot E, Toledo-Arana A, Lin AE, Enninga J, Pizarro-Cerdá J, Finlay BB, Kirchhausen T, et al. Invasive and adherent bacterial pathogens co-opt host clathrin for infection. Cell Host Microbe 2007;2:340-351.
46. Billingsley ML, Yun J, Reese BE, Davidson CE, Buck-Koehntop BA, Veglia G. Functional and structural properties of stannin: Roles in cellular growth, selective toxicity, and mitochondrial responses to injury. J Cell Biochem 2006;98:243-250.